These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14446409)

  • 1. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 8. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].
    LECOMTE J; LAPIERE CM
    C R Seances Soc Biol Fil; 1960; 154():2386-9. PubMed ID: 13760117
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR; REED AF
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract]   [Full Text] [Related]  

  • 13. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
    DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199
    [No Abstract]   [Full Text] [Related]  

  • 15. Blockade of 5-hydroxytryptamine antidiuresis in rats by 2-bromlysergic acid diethylamide tartrate and 1-methyl-lysergic acid butanolamide.
    CHODERA A
    J Pharm Pharmacol; 1963 Jun; 15():386-9. PubMed ID: 14020952
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
    ABRAMSON HA
    J Asthma Res; 1964 Mar; 1(3):207-11. PubMed ID: 14135439
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the prophylactic treatment of migraine with deseril].
    DALSGAARD-NIELSEN T
    Praxis; 1960 Sep; 49():867-8. PubMed ID: 13719474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.